At ATRAL Laboratories, we understand that product logistics is not just the product itself, but a combination of product and data.
Taking this into account and within the framework of legal provisions for the serialization of medicines (Directive on Counterfeit Drugs – 2011/62 / EU) and subsequently Delegate Act 2016/161, we are pleased to confirm that ATRAL has adopted all necessary procedures to meet the requirements of this new legislation.
ATRAL has acquired and adopted all the necessary equipment to start producing according to the new legislation from January 2019.